论文部分内容阅读
据英国广播公司报道,从10月30日开始,欧盟将改变有关草药管理规定,要求制药商今后必须提供产品安全性的证明,保证产品质量标准一贯性,并向顾客系统介绍产品信息及使用方法。欧盟管理当局表示,迄今为止,消费者一直无法了解市场上出售的草药产品是否符合治疗标准。这样一方面导致那些对消费者负责的公司为保证草药质量而在经济上遭受损失,同时致使消费者可能受到劣质产品的损害。从10月30日开始,如果制药商无法证明产品的安全性或没有向消费者提供使用方法的信息,有关草药就不得注册,不得上市;而目前已在市场出售的草药产品也必须根据新规定提供相关信息。欧盟指出,新规定旨在保证欧盟范围内所有消费者在使用草药时都可以对产品有更多的了解,并得到更好的保护。
According to the BBC, starting from October 30, the EU will change its regulations on herbal medicines and require manufacturers to provide evidence of product safety in the future, to ensure the consistency of product quality standards and to introduce product information and usage methods to customer systems . EU authorities said so far consumers have been unable to understand whether the herbal products sold on the market meet the treatment standards. This on the one hand leads to those responsible for the consumer company to ensure the quality of herbal medicine in the economic losses, while causing consumers may be inferior products damage. From October 30, if the manufacturer can not prove the safety of the product or does not provide the consumer with information on the method of use, the relevant herbal product may not be registered and may not be listed. Herbal products currently on the market must also be sold in accordance with the new regulations Provide relevant information. The EU pointed out that the new regulation aims to ensure that all consumers in the EU can learn more about products and get better protection when using herbs.